Pawel R Kiela

Title: Pawel R Kiela: Innovator in Targeted Drug Delivery

Introduction

Pawel R Kiela is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of targeted drug delivery systems. With a total of 2 patents, Kiela's work focuses on improving the efficacy of drug administration in the gastrointestinal tract.

Latest Patents

Kiela's latest patents include innovative solutions for drug delivery. One of his patents is titled "Nitroreductase-releasable pro-drugs and methods for using the same." This invention provides a nitroreductase-releasable pro-drug that is useful in oral administration to treat various clinical conditions associated with the distal gut region, such as colorectal cancer and inflammatory bowel disease. Another significant patent is "Method and compositions for targeted drug delivery to the lower GI tract." This patent describes a composition and method for delivering substances to the lower GI tract, where bacterial enzymes cleave bonds to release the drug, allowing for targeted treatment.

Career Highlights

Kiela has worked with reputable institutions, including the University of Arizona and the Arizona Board of Regents on behalf of the University of Arizona. His research has contributed to advancements in pharmaceutical sciences and drug delivery mechanisms.

Collaborations

Kiela has collaborated with esteemed colleagues such as Eugene A Mash and Fayez K Ghishan. Their combined expertise has furthered research in the field of gastrointestinal drug delivery.

Conclusion

Pawel R Kiela's innovative work in targeted drug delivery showcases his commitment to improving therapeutic outcomes for patients. His patents reflect a deep understanding of pharmaceutical science and a dedication to addressing complex medical challenges.